Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Kapa Biosystems Extends Exclusive Japanese Distribution Agreement with Nippon Genetics

Published: Monday, August 04, 2014
Last Updated: Friday, August 08, 2014
Bookmark and Share
Latest agreement builds on continued commercial success of Kapa’s genomics product portfolio over the past seven years in the Japanese market.

Kapa Biosystems has signed a new three-year exclusive distribution agreement with Nippon Genetics Co., Ltd., further extending the successful seven-year relationship between the companies and enabling Nippon Genetics to continue marketing, distributing, and servicing Kapa Biosystems’ genomics reagents in Japan. This agreement is a key part of Kapa Biosystems corporate growth strategy and the first of several key commercial announcements that will be made later this year.

Kapa Biosystems offers a portfolio of advanced reagents for use in PCR, qPCR, next-generation sequencing, and molecular diagnostics applications. The reagents contain novel enzymes—engineered via directed evolution—that confer significant performance advantages when compared to traditional wild-type enzymes. Many of the products are optimized for challenging samples and high-throughput workflows, and include pre-validated scripts using the leading liquid-handling automation platforms.

“The genetic research and applied markets in Japan are growing exponentially and many scientists rely on us to deliver high-quality and reliable solutions,” said Kazuo Yamazaki, CEO and President, Nippon Genetics Co., Ltd. “Kapa Biosystems products fit perfectly within our innovative life science offerings and enable us to provide more complete solutions to our customers.”

Over the past year, Kapa Biosystems has added several proven industry veterans to its management team and more than doubled the company’s previous facility investment to scale enzyme production, quality control, and manufacturing capacity across its various business franchises. Over the next few months, the company plans on announcing several other key distribution agreements and corporate initiatives to better support the growing number of customers around the world.

“With more than 25 years of experience working with cutting edge technologies and strong relationships with the key opinion leaders in Japan, Nippon Genetics is the ideal distribution partner for our business,” said Jean-Christophe Hatinguais, Director of International Sales, Kapa Biosystems. “We are seeing broad adoption and strong demand for our innovative products not only in Japan, but across the Asia Pacific, European, and North American regions. We are now focused on extending our global reach by increasing our strategic investments and expanding our distribution network in key markets.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
‘Mutation-Tracking’ Blood Test for Breast Cancer
Scientists have developed a blood test for breast cancer able to identify which patients will suffer a relapse after treatment, months before tumours are visible on hospital scans.
Common ‘Heart Attack’ Blood Test May Predict Future Hypertension
Small rises in troponin levels may have value as markers for subclinical heart damage and high blood pressure.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
'Fountain of Youth' Protein Points to Possible Human Health Benefit
Patients with higher blood levels of growth factor have lower risk of cardiovascular problems.
Signature of Microbiomes Linked to Schizophrenia
Studying microbiomes in throat may help identify causes and treatments of brain disorder.
Imaging Software Could Speed Breast Cancer Diagnosis
Technology could improve access to diagnostic services in developing countries.
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
Data Mining DNA For Polycystic Ovary Syndrome Genes
A new Northwestern Medicine genome-wide association study of PCOS – the first of its kind to focus on women of European ancestry – has provided important new insights into the underlying biology of the disorder.
Algorithm Interprets Breathing Difficulties to Aid in Medical Care
Researchers from North Carolina State University have developed an efficient algorithm that can interpret the wheezing of patients with breathing difficulties to give medical providers information about what’s happening in the lungs.
Researchers Develop qPCR Prognosis Test for NSCLC Patients
A nine-gene molecular prognostic index (MPI) for patients with early-stage non-small cell lung cancer (NSCLC) was able to provide accurate survival stratification and could potentially inform the use of adjuvant therapy in patients struggling with the disease.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!